Target intelligence / Profile preview

Long intergenic non-protein coding RNA 3110 (LINC03110)

Target
LINC03110
Molecular classification
Long non-coding RNA (lncRNA), Long intergenic non-coding RNA (lincRNA)
01

Overview

Long intergenic non-protein coding RNA 3110 (LINC03110) is an autonomously transcribed non-coding RNA longer than 200 nucleotides, located between annotated protein-coding genes in the human genome[3]. Like other lincRNAs, it is marked by chromatin features characteristic of active transcription, but does not overlap with protein-coding regions[3][5]. LincRNAs frequently function to regulate expression of nearby or distant genes—sometimes mediating chromatin remodeling, influencing three-dimensional genome architecture, or acting as molecular scaffolds and sponges for microRNAs[3][5]. Although many lincRNAs are emerging as cellular regulators and some are implicated in disease processes, there is no published evidence to date linking LINC03110 to specific biological functions, pathologies, or therapeutic relevance[1]. The field is actively evolving as more lincRNAs are annotated and their functions elucidated[3][5]. No documentation supports the inclusion of LINC03110 among canonical drug targets, clinical biomarkers, or disease-associated entities at the current time[1][3][5].

Other names
LINC03110long intergenic non-coding RNA 3110
02

Mechanism of action

None documented. There are no known drug mechanisms of action targeting LINC03110

03

Biological functions

Chromatin remodelingTranscription regulation (may act as an enhancer-associated RNA)RNA stabilizationFine-tunes expression of neighboring genesCell growth and apoptosisDevelopmentImprintingDosage compensation
04

Disease associations

Other

Beyond the preview

Go deeper on Long intergenic non-protein coding RNA 3110 (LINC03110).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Long intergenic non-protein coding RNA 3110 (LINC03110).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call